Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
Clinical trial NCT03951077 · COMPLETED
Trial details
- NCT number
- NCT03951077
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-12
- Primary completion
- 2021-02-10
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.